Decreased phosphatase PTEN amplifies PI3K signaling and enhances proinflammatory cytokine release in COPD by Yanagisawa, S, Baker, JR, Vuppusetty, C, Fenwick, P, Donnelly, LE, Ito, K, Barnes, PJ

Decreased Serum Sirtuin-1 in COPD by Yanagisawa, S, Papaioannou, AI, Papaporfyriou, A, Baker, JR, Vuppusetty, C, Loukides, S, Barnes, PJ, Ito, K

MicroRNA-570 is a novel regulator of cellular senescence and inflammaging by Baker, JR, Vuppusetty, C, Colley, T, Hassibi, S, Fenwick, PS, Donnelly, LE, Ito, K, Barnes, PJ

The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure by Yanagisawa, S, Baker, JR, Vuppusetty, C, Koga, T, Colley, T, Fenwick, P, Donnelly, LE, Barnes, PJ, Ito, K

Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells by Baker, JR, Vuppusetty, C, Colley, T, Papaioannou, AI, Fenwick, P, Donnelly, L, Ito, K, Barnes, PJ

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019 by Singh, D, Agusti, A, Anzueto, A, Barnes, PJ, Bourbeau, J, Celli, BR, Criner, GJ, Frith, P, Halpin, DMG, Han, M, López Varela, MV, Martinez, F, Montes De Oca, M, Papi, A, Pavord, ID, Roche, N, Sin, DD, Stockley, R, Vestbo, J, Wedzicha, JA, Vogelmeier, C

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial by Yu, L-M, Bafadhel, M, Dorward, JJ, Hayward, G, Saville, BR, Gbinigie, O, Van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Richards, D, Berry, N, Detry, MA, Saunders, C, Fitzgerald, M, Harris, V, Shanyinde, M, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Ramakrishnan, S, Hobbs, FDR, Butler, CC, Yu, L-M, Bafadhel, M, Dorward, J, Hayward, G, Saville, BR, Gbinigie, O, van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Richards, D, Berry, N, Detry, MA, Saunders, CT, Fitzgerald, M, Harris, V, Shanyinde, M, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Ramakrishnan, S

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial by Yu, L-M, Ramakrishnan, S, Bafadhel, M, Dorward, J, Hayward, G, Saville, BR, Gbinigie, O, van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Berry, N, Detry, MA, Saunders, CT, Fitzgerald, M, Harris, V, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Hobbs, FDR, Butler, CC

Current controversies in chronic obstructive pulmonary disease. A report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee by Criner, GJ, Martinez, FJ, Aaron, S, Agusti, A, Anzueto, A, Bafadhel, M, Barnes, PJ, Bourbeau, J, Chen, R, Ewig, J, Fabbri, LM, Frith, P, Halpin, DMG, Han, M, De Oca, M, Nishimura, M, O'Donnell, D, Papi, A, Pavord, I, Roche, N, Rodriguez-Roisin, R, Salvi, S, Singh, D, Sin, DD, Stockley, R, Varela, MV, Vestbo, J, Vogelmeier, CF, Washko, G, Wedzicha, JA, Celli, BR